Sean F. Scanlan - 24 Oct 2022 Form 4 Insider Report for TREACE MEDICAL CONCEPTS, INC. (TMCI)

Role
SVP, Marketing
Signature
/s/ Lisa Taylor as Attorney-in-fact for Sean Scanlan
Issuer symbol
TMCI
Transactions as of
24 Oct 2022
Net transactions value
$0
Form type
4
Filing time
26 Oct 2022, 18:03:36 UTC
Previous filing
10 Mar 2022
Next filing
16 Nov 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction TMCI Common Stock Award $0 +3,400 +52% $0.000000 9,975 24 Oct 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TMCI Stock Option (Right to Buy) Award $0 +23,000 $0.000000 23,000 24 Oct 2022 Common Stock 23,000 $9.83 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents restricted stock units ("RSUs") for which the Reporting Person is entitled to receive one (1) share of issuer's Common Stock for each RSU upon vesting. The RSUs vest in equal annual installments over 4 years, commencing on October 24, 2023 with the last installment on October 24, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date.
F2 Includes 9,975 RSUs.
F3 The stock option will vest in equal annual installments over 4 years, commencing on October 24, 2023 with the last installment on October 24, 2026; subject to Reporting Person's providing continued service to Issuer through each vesting date.